ASP Isotopes

ASP Isotopes Stock-Based Compensation

The Stock-Based Compensation (SBC) of ASP Isotopes (ASPI) as of Nov 18, 2026 is 16.02 M USD. In the previous year, Stock-Based Compensation (SBC) was 8.56 M USD — a change of 87.17% (higher).

Stock-Based Compensation

16.02 MUSD

YoY

87.17%

Last updated:

Stock-Based Compensation (SBC) of ASP Isotopes is 2025 16.02 M USD. Stock-Based Compensation (SBC) of ASP Isotopes was 2024 8.56 M USD. It decreases by 87.17% higher compared to the previous year.

The ASP Isotopes Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2022
2.00 M USD
Jan 1, 2023
8.74 M USD
Jan 1, 2024
8.56 M USD
Jan 1, 2025
16.02 M USD
The ASP Isotopes Stock-Based Compensation history
YEARStock-Based CompensationYoY
16.02 MUSD+87.17%
8.56 MUSD-2.09%
8.74 MUSD+337.34%
2.00 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ASP Isotopes Stock analysis

What does ASP Isotopes do? ASP Isotopes, Inc. generates revenue through the development and commercialization of enriched isotopes using its Aerodynamic Separation Process (ASP technology). The company focuses on producing Carbon-14 (C-14), Molybdenum-100 (Mo-100), and Silicon-28 (Si-28) for specialized markets, with plans to expand into Uranium-235 (U-235) for the nuclear energy sector. Its subsidiaries, ASP Isotopes Guernsey Limited and Enriched Energy LLC, handle high-value isotope production and uranium development, respectively. The company licenses ASP technology from Klydon Proprietary Ltd for all isotope-related activities. The target customers for C-14, Mo-100, and Si-28 are highly specialized end markets requiring low-volume, high-value isotopes. Enriched Energy LLC specifically targets the nuclear energy market with uranium products. ASP Isotopes Guernsey Limited focuses on niche applications where isotope enrichment is critical, such as medical and industrial uses. The company’s revenue model relies on the sale of these enriched isotope products to specialized industries rather than mass-market consumers. ASP Isotopes, Inc. operates under a pre-commercial stage, meaning it is still developing its production capabilities and has not yet achieved full-scale commercialization. The company’s initial revenue streams will come from the sale of C-14, Mo-100, and Si-28, with future expansion into U-235 expected to diversify its product portfolio. The Aerodynamic Separation Process (ASP technology) is central to its business model, enabling the enrichment of natural isotopes into higher concentration products for specialized applications. ASP Isotopes is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ASP Isotopes stock

Stock-Based Compensation (SBC) of ASP Isotopes is 16.02 M USD in 2025.

Stock-Based Compensation (SBC) of ASP Isotopes changed from 8.56 M USD to 16.02 M USD, representing a 87.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) ASP Isotopes since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s ASP Isotopes historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — ASP Isotopes

All Key Metrics — ASP Isotopes